Facebook Twitter
Now With Over 21,000 Reviews!
Sign up now and see how you can quickly earn 20 ivBucks.

@biorunup

Biotech trader and Columnist at TheStreet utilizing long, short & options based strategies to maintain consistent gains in any market. Come trade with BioRunUp!
 
 
 
24 Total Reviews
Overall:
 
5-Star       (9)
4-Star       (5)
3-Star       (4)
2-Star       (4)
1-Star       (3)
   
Top Review
 
Biotech Freakkk
Biorunup is a great follow on twitter if you are even considering trading biotch stocks. His twitter name is self explanatory of his...
boone_trader
 
Show:  
Sort:  
Page:   1
Displaying 1-10 of 24 Total Reviews
good


This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



Amateur Hour in Biotech Due Diligence
An IT guy sitting at cubicle turned biotech trader running a biotech service? Other than front running alerts of bought 1000 shares of XZY and sold 2000 shares of ABC (these are typically $4-5 stocks, so not that big of position BTW) the service does not provide any value and is not worth the $$$$. The site's whole foundation is based around FDA approval dates but these can be obtained for free at other websites. If you want true biotech due diligence I highly recommend Chimera Research Group. These guys actually have degrees in Statistics, PhD and provide true valuable and actionable diligence report for biotech trading.

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
0 of 1 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated
Amateur Hour in Biotech Due Diligence
An IT guy sitting at cubicle turned biotech trader running a biotech service? Other than front running alerts of bought 1000 shares of XZY and sold 2000 shares of ABC (these are typically $4-5 stocks, so not that big of position BTW) the service does not provide any value and is not worth the $$$$. The site's whole foundation is based around FDA approval dates but these can be obtained for free at other websites. If you want true biotech due diligence I highly recommend Chimera Research Group. These guys actually have degrees in Statistics, PhD and provides valuable and actionable diligence report for biotech trading.

This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



Up over 70% YTD
I just play long/short and have turned 100k into over 170k in roughly 6 months. I'll be honest biotechs were super hot this summer but my ideas came from biorunup and fellow subscribers. Great for people who only have an hour or two a day. Watch the game plans and execute. pretty straight forward. Beauty is even if you dont catch the trade right as it happens there is still plenty of time to make money.

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
1 of 1 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



Good on Bios
A good follow for biotech players. Even though he runs a premium service he still puts out quality tweets for the non subs. Always positing bio news and retweeting other bio tweets. Good one stop shop for some bio information.

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
1 of 1 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



Non-expert bio traders
I did not renew my biorunup subscription because these guys aren't the experts in bio stocks that they claim to be. One year ago, they sold me on their service based on their research, recommendations, valuation studies, and 'lack of pumping and dumping like on the Yahoo message boards'. At first, for the first quarter of the year, I thought that they really had good insight in the biotech field, when most of their selections were moving up. Then, most of their recommendations went flat or lost moeny.

Looking back, I see that Mike made most of his profits by going nearly all in on two stocks in 2010 (EXAS and AMRN), but lost big in 2011 by going nearly all in with LCI and BDSI. Now, Mike is working part time again, and has taken a lot of his money out of his portfolio. Mark still trades, but has made most of his money by trading the biorundowns via his other subscription service with Welsh, Skeptical Trader. He has also taken a lot of his money out of his portfolio. (I guess they are making all their money by selling subscriptions, books, dvds, t-shirts, etc.)

Their runup valuation reports were inconsistent and usually off base (there is no hsitorical data comparing their reports vs. actual results). The forum is dead. Their webinars and tweets are usually just pumps and pans of what they are long and short on, just like the Yahoo boards which Mark so despises. They may put out an article, saying they are going long and expecting a significant price appreciation, and then a few days later they are out with little or no gain - which you can do on any other stock in the rest of the market. Also, there are other free sites that have an FDA calendar ad data base.

Don't get me wrong, because I do think they are both straight up guys. I think they try to be honest and forthcoming, although Mark's profitly is usually behind. However, I don't see the value in what they claim to do for you.

THE BOTTOM LINE IS THAT THEY ARE BASICALLY GUESSING AND REALLY NOT PROVIDING ANY GREAT INSIGHT.

(I will probably be flamed for gving this review, but I think a lot of folks have not renewed. Their recent ASH recommendations were a diaster, as well as their summer/fall runup selections of CLSN, BPAX, EXEL, IGXT and PATH to name a few.)

GLTA

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
1 of 2 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



Tried the service....thumbs down
Not much to it. Mark bot 2000 XYZ, Mike bot 600 TYB and it really ads no value. They are transparent and profitable. This service is for the swing traders, Not the momentum traders. Everyone thinking about giving them a try should understand this distinction.

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
2 of 2 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



He's a tool (My research tool), Transparent, Honest
I've watched listened and chatted with mark. I think very highly of him. Although he will no recommend stocks (disclaimer) he is always there when I need a quick answer or advice.

Trading in this market is a bit scary and having another one with skin in the game and watching him perform over time has built a great deal of trust.

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
2 of 2 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



What a sensitive guy
Lol, I just found out today that biorunup blocked me a few days ago from seeing his tweets, when I realized I hadn't seen him market himself in a while. Couldn't figure out why he would block me since I have a whopping 12 followers and send out maybe a tweet a week, but I went back and looked and realized how I joined along with a few popular twitter trader's in making fun of his service when i agreed with the other twitter person that it was a waste of money. Eh, no big loss but as a review: Most of his tweets are of no value and they're just marketing attempts (90%). You're not going to get much stock idea's listening to him other than him constantly saying how good or bad a stock is after he's bought some options/stocks on them (5%). The other 5% would have to be him constantly trying to get approval and acceptance from the other popular twitter trader's out there. Kinda surprised there aren't more lower star reviews on this guys twitter accnt on investimonials.....almost like someone deliberatley removed them...Was an amusing follow while it lasted...sigh

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
2 of 3 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
3 Comments on this Review
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



uncanny perspicacity
Great information and frequent and timely.

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
1 of 1 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



BIORUNUP a very new paid service, not easy to review
Mike Havrilla has a tremendous background in biotech/pharmaceutical and gives depth to a formula that many biotech traders use: easing into a position prior to a specific event and hoping to minimize the risk of dilution by entering into companies that have cash. Sadly, some companies that are close to a perceived approval begin to need cash again for manufacturing and so the risk of dilution is a constant.

Mark is less well known, having entered some trades on a public twitter and managing them quite well, with his plan to exit before the FDA event. Mark seems to have a promotional gene that few on twitter display: it's a good thing for his service. He began Biorunup before Mike's association and works very hard to enrich the experience with a forum, daily emails, a private twitter feed, SMS alerts, in depth reviews of some biotech.

I began by saying how difficult this review is for me: it certainly is. I've done biotech both on my own, using Adam Feurstein's reports as a starting place and periodically a subscriber of Shark Biotech (very deep articles, very understanding of biotech) and Mark's public twitter feed was certainly friendly.Happy to subscribe, very nice that Mike is there and that they continue to enrich the site. They are usually involved with maybe six or seven stocks at a time, sometimes buying calls in addition to stock; sometimes puts.

The thing that they have not addressed is the issue of front running. No more so than any twitter trader or paid service with a few thousand followers but Mark and Mike notify during market hours through the private twitter feed: delivery is not immediate with twitter’s many issues. The sells are made before notifying the paid followers. Please note that this does not universally bother subscribers: many, perhaps most, are exceedingly happy. From time to time Mark issues public tweets of his trades: again, that may bother very few subscribers -but that is something that smacks of promotion or stock pumping in a bad way. My hope is that while they manage their personal trading accounts, they find better ways to send trading alerts to subscribers. There’s several valid ways that don’t immediately spike the price. Happy they do well but in my opinion a subscription service must be for the benefit of the subscriber base first.

Mark and Mike send relatively frequent tweets promoting the service: it's a business that they take seriously and I can't see why that would upset anyone. I was surprised in a disappointed way at the recent announcement that they will begin a new service, BioRunDown. Hmmmm. Not liking that a bit but their business choice. Effectively and ironically, the original paid BioRunUp service is now being diluted.

I do appreciate the entrepreneurial spirit: DVD's, books, Tshirts and soon two paid services instead of the one.

I'm very surprised that very obvious (to me) trades are ignored. ITMN was not part of the recommendations and yet was an obvious stock to watch. Having been in for the first runup from 13 to 38 (it had run to the 40's) and then watching in horror as it returned to 13, I picked up a few April '11 calls. Much to my surprise, the European Review sent it skyrocketing from 13 to 38 again. The exact timing of a large run up was the only surprise. Calls were dirt cheap and really paid off.

HGSI is another that no work has been done on with its FDA date of March 10 and its unique likelihood of approval with black boxes. Because it's the only possible new drug in fifty years, it would be highly likely to have a run up. DCTH at 5.00 yelled to be picked up.

I don’t find the price expensive or inexpensive for a beginning service: it is what it is. While many features and now products have been added, I do think that more biotech must be covered to sustain good growth. My hope is that Mike steps that part up with his unique and valuable expertise. I cannot say enough good things about Mike’s background and sort of intuitive sense of biotech trading.

The point is that for many people the service is sufficient to make a lot of money, with just the usual risks of biotech. For traders who regularly swing biotech, it's a good supplement but not enough. It is, in fairness, for Mike who has amazing verified returns.

Some traders would be uncomfortable handling more than five at a time and others, like me, equally uncomfortable at not having a basket with a minimum of ten or twelve to avoid the catastrophe of a blowup on one or two in a light basket.

I would certainly recommend this as a resource: a good supplement to a well-rounded biotech trader's list.

It’s a very new service with two very smart energized men working on it full time. Because they continue to implement good changes to the site, I hope that they will iron out the issues that are important to the subscribers and continually add coverage beyond the handful that wish to personally trade.

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
2 of 2 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
3 Comments on this Review
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.

Overall Rating
Education
Entertainment
Frequency



Page:   1
Displaying 1-10 of 24 Total Reviews
Recommended For
 
Investimonials Sponsors
 
Featured Investing Products
  
  
  
  
  
  
  
  
 
 
The Wolf of Wall Street Movie  4 New ReviewsEmini Academy  8 New Reviewsoptionshouse  3 New ReviewsWinningStockCoach  20 New ReviewsSeeking Alpha  6 New ReviewsWandering Trader  13 New ReviewsThe OptionTiger  11 New Reviews1 Option  21 New ReviewsThe Lincoln List  4 New ReviewsReaper Trades  3 New ReviewsTheDayTradingAcademy  5 New ReviewsSureTrader  8 New ReviewsTheTechnicalTrader  17 New ReviewsBreak Point Trades  14 New ReviewsStage 5 Trading Corp  17 New ReviewsJason Bond Picks  16 New ReviewsTDAmeritrade  6 New ReviewsJapanese Candlestick Charting Techniques, Second Edition  4 New ReviewsShortStocking DVD  4 New ReviewsPennystocking Silver  6 New ReviewsHow I Made $2,000,000 in the Stock Market  3 New Reviews@super_trades  3 New ReviewsThe Stock Swoosh  6 New ReviewsDay Trading Radio  6 New ReviewsBigcharts  3 New ReviewsSuperNova Stocks  4 New ReviewsTradeKing  3 New ReviewsLiteForex (Lite Forex)  12 New ReviewsNinja Trader   4 New ReviewsInvestopedia.com  4 New ReviewsInvestors Hub  3 New ReviewsReminiscences of a Stock Operator Annotated Edition  4 New ReviewsSteadyOptions  16 New ReviewsTIMfundamentals  3 New ReviewsInvestors Live  3 New ReviewsInvestors Live: Textbook Trading DVD  37 New ReviewsTIMfundamentals Part Deux   3 New ReviewsThe Wolf of Wall Street  3 New ReviewsSuperman Trade Alerts  8 New ReviewsStockcharts.com  3 New ReviewsTradingHub.Co  4 New ReviewsDayTradingZones  4 New ReviewsC squared Trading Alerts  5 New ReviewsAn American Hedge Fund: How I Made $2 Million as a Stock Operator & Created a Hedge Fund  3 New ReviewsT3 Capital Management  3 New ReviewsAlpha 7 Trading Academy  10 New ReviewsiTrading App  16 New ReviewsInvestors Underground: Live Trading Chatroom  5 New ReviewseSignal  3 New ReviewsJim Cramer's Action Alerts Plus  3 New ReviewsApex Futures  3 New Reviews@investorslive  3 New ReviewsSharePlanner.com  8 New ReviewsTIMAlerts Monthly  6 New ReviewsSpeed Trader  8 New ReviewsJigsaw Trading   32 New ReviewsProphet Alerts  3 New ReviewsThe Snowball: Warren Buffett and the Business of Life   3 New ReviewsYahoo! Finance  4 New ReviewsMarketWatch  3 New ReviewsThinkOrSwim  12 New ReviewsBloomberg  4 New ReviewsInteractive Brokers  8 New ReviewsPicks That Make Cents  13 New ReviewsThe Art of Warfare  3 New ReviewsPennyStocking Part Deux  5 New ReviewsG6 Trading  5 New ReviewsSuper Trades  3 New ReviewsFous Alerts  9 New ReviewsFreeStockCharts.com  6 New ReviewsFOUS4  4 New ReviewsSchool of Trade  9 New ReviewsPennyStocking DVD  4 New ReviewsBioRunUp  3 New ReviewsBuffett: The Making of an American Capitalist  4 New ReviewsFinViz  3 New Reviews